In Haiti, patients randomised to start ART with CD4 counts from 200-350 cells/mm3 had a two-fold lower risk of TB compared to those who were randomised to defer ART until their CD4 count dropped below 200 cells/ mm3 [127]. The gene discussed is CD4; the disease is tuberculosis.